Evolent Health, Inc. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-04-28: Measure Adjusted EBITDA.
- 2023-04-28: Measure Revenue Growth.
- 2023-04-28: Measure Employee engagement.
- 2023-04-28: Measure Total Shareholder Return.
| Proxy filed | Measure |
|---|---|
| 2023-04-28 | Adjusted EBITDA |
| 2023-04-28 | Revenue Growth |
| 2023-04-28 | Employee engagement |
| 2023-04-28 | Total Shareholder Return |
| 2023-04-28 | Stock Price |
| 2024-04-26 | Adjusted EBITDA |
| 2024-04-26 | Revenue Growth |
| 2024-04-26 | Quarterly exit run rate |
| 2024-04-26 | Employee engagement |
| 2024-04-26 | Total Shareholder Return |
| 2024-04-26 | Stock Price |
| 2025-04-25 | Adjusted EBITDA |
| 2025-04-25 | Revenue Growth |
| 2025-04-25 | Revenue Bookings Growth |
| 2025-04-25 | Employee engagement |
| 2025-04-25 | Total Shareholder Return |
| 2025-04-25 | Stock Price |
| 2026-04-24 | Adjusted EBITDA |
| 2026-04-24 | Revenue Growth |
| 2026-04-24 | Revenue Bookings Growth |
| 2026-04-24 | Employee engagement |
| 2026-04-24 | Total Shareholder Return |
| 2026-04-24 | Stock Price |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |